Citadel Advisors »

Biodexa Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Biodexa Pharmaceuticals (BDRX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Biodexa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biodexa Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biodexa Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $30k 33k 0.90

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Citadel Advisors

Top funds holding Biodexa Pharmaceuticals

Virtu Financial
Citadel Advisors
Susquehanna International
Two Sigma Securities
Ground Swell Capital
GAMMA Investing
Rhumbline Advisers
UBS Group
Contravisory Investment Management
Bank of America Corporation
Morgan Stanley
Headlands Technologies

View all funds holding Biodexa Pharmaceuticals